Author Correction: Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2 (Nature Communications (2017) 8 (13997) DOI: 10.1038/ncomms13997);Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2

Nature Communications

Volumn 8, Issue , 2017, Pages

  Wang, Yi ^a   Qian, Yuanyuan ^a   Fang, Qilu ^a   Zhong, Peng ^a   Li, Weixin ^a   Wang, Lintao ^a   Fu, Weitao ^a   Zhang, Yali ^a   Xu, Zheng ^a   Li, Xiaokun ^a   Liang, Guang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; L6H9; PALMITIC ACID; PROTEIN MD 2; SATURATED FATTY ACID; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; LY96 PROTEIN, MOUSE; PROTEIN BINDING; TLR4 PROTEIN, MOUSE;

CARDIOVASCULAR DISEASE; FATTY ACID; IMMUNE SYSTEM; IMMUNITY; INJURY; MUSCLE; OBESITY; PROTEIN; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; EMBRYO; EXPERIMENTAL MYOCARDITIS; HEART MUSCLE INJURY; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KNOCKOUT GENE; LIPID DIET; MALE; MOLECULAR DOCKING; MOUSE; NONHUMAN; OBESITY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CARDIOMYOPATHY; CELL LINE; CHEMISTRY; DEFICIENCY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; RAT; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; CARDIOMYOPATHIES; CELL LINE; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ANTIGEN 96; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR DOCKING SIMULATION; MYOCYTES, CARDIAC; OBESITY; PALMITIC ACID; PROTEIN BINDING; RATS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 85008339359     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms16185     Document Type: Erratum

References (68)

1. Smith, K. B. & Smith, M. S. Obesity statistics. Prim. Care 43, 121-135ix (2016).
2. Poirier, P. & Eckel, R. H. in Hurst's The Heart (eds Fuster V. et al.) (McGraw-Hill Companies, 2000).
3. Cavalera, M., Wang, J. & Frangogiannis, N. G. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl. Res. 164, 323-335 (2014).
4. Abel, E. D., Litwin, S. E. & Sweeney, G. Cardiac remodelling in obesity. Physiol. Rev. 88, 389-419 (2008).
5. Wang, Z. & Nakayama, T. Inflammation, a link between obesity and cardiovascular disease. Mediators. Inflamm. 2010, 535918 (2010).
6. Ilkun, O. & Boudina, S. Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies. Curr. Pharm. Des. 19, 4806-4817 (2013).
7. Reyna, S. M. et al. Elevated Toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57, 2595-2602 (2008).
8. Gordon, E. S. Non-esterified fatty acids in the blood of obese and lean subjects. Am. J. Clin. Nutr. 8, 740-747 (1960).
9. Pilz, S. & Marz, W. Free fatty acids as a cardiovascular risk factor. Clin. Chem. Lab. Med. 46, 429-434 (2008).
10. Pilz, S. et al. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J. Clin. Endocrinol. Metab. 91, 2542-2547 (2006).
11. Jakobsen, M. U. et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr. 89, 1425-1432 (2009).
12. Ubhayasekera, S. J., Staaf, J., Forslund, A., Bergsten, P. & Bergquist, J. Free fatty acid determination in plasma by GC-MS after conversion to Weinreb amides. Anal. Bioanal. Chem. 405, 1929-1935 (2013).
13. Staaf, J. et al. Initial hyperinsulinemia and subsequent beta-cell dysfunction is associated with elevated palmitate levels. Pediatr. Res. 80, 267-274 (2016).
14. Huang, S. et al. Saturated fatty acids activate TLR-mediated proinflammatory signalling pathways. J. Lipid Res. 53, 2002-2013 (2012).
15. Lee, J. Y., Sohn, K. H., Rhee, S. H. & Hwang, D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276, 16683-16689 (2001).
16. Schaeffler, A. et al. Fatty acid-induced induction of Toll-like receptor- 4/nuclear factor-kB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126, 233-245 (2009).
17. Kennedy, A., Martinez, K., Chuang, C. C., LaPoint, K. & McIntosh, M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J. Nutr. 139, 1-4 (2009).
18. Gupta, S., Knight, A. G., Gupta, S., Keller, J. N. & Bruce-Keller, A. J. Saturated long-chain fatty acids activate inflammatory signalling in astrocytes. J. Neurochem. 120, 1060-1071 (2012).
19. Zeng, C. et al. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-kappaB both in vitro and in vivo. J. Mol. Cell. Cardiol. 79, 1-12 (2015).
20. Alvarez-Guardia, D. et al. PPARb/d activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. Biochim. Biophys. Acta 1811, 59-67 (2011).
21. Ying, Y., Zhu, H., Liang, Z., Ma, X. & Li, S. GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway. J. Mol. Endocrinol. 55, 245-262 (2015).
22. Kim, F. et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100, 1589-1596 (2007).
23. Eguchi, K. et al. Saturated fatty acid and TLR signalling link b cell dysfunction and islet inflammation. Cell. Metab. 15, 518-533 (2012).
24. Tian, H. et al. MiRNA-194 regulates palmitic acid-induced toll-like receptor 4 inflammatory responses in THP-1 cells. Nutrients 7, 3483-3496 (2015).
25. Maloney, E. et al. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler. Thromb. Vasc. Biol. 29, 1370-1375 (2009).
26. Milanski, M. et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signalling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 29, 359-370 (2009).
27. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
28. Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30, 16-34 (2011).
29. Moghimpour Bijani, F., Vallejo, J. G. & Rezaei, N. Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities. Int. Rev. Immunol. 31, 379-395 (2012).
30. Park, B. S. et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191-1195 (2009).
31. Marino, M. et al. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. J. Neuroimmunol. 196, 41-48 (2008).
32. Wu, J. et al. Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents. J. Med. Chem. 54, 8110-8123 (2011).
33. Jadhav, A., Tiwari, S., Lee, P. & Ndisang, J. F. The heme oxygenase system selectively enhances the anti-inflammatory macrophage-M2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in Zucker diabetic fatty rats. J. Pharmacol. Exp. Ther. 345, 239-249 (2013).
34. Nguyen, M. T. et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282, 35279-35292 (2007).
35. Lee, J. Y. et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279, 16971-16979 (2004).
36. Jang, H. J., Kim, H. S., Hwang, D. H., Quon, M. J. & Kim, J. A. Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin. Am. J. Physiol. Endocrinol. Metab. 304, E1077-E1088 (2013).
37. Dasu, M. R. & Jialal, I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am. J. Physiol. Endocrinol. Metab. 300, E145-E154 (2011).
38. Senn, J. J. Toll-like receptor-2 is essential for the development of palmitateinduced insulin resistance in myotubes. J. Biol. Chem. 281, 26865-26875 (2006).
39. Eguchi, K., Manabe, I. & Nagai, R. Inflammation induced by free-fatty acid-tlr4/myd88 signalling in non-immune cells play a pivotal role in both cardiovascular and metabolic diseases. Circulation 126, A11813 (2012).
40. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015 (2006).
41. Wong, S. W. et al. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 284, 27384-27392 (2009).
42. Li, H. & Li, C. Multiple ligand simultaneous docking: orchestrated dancing of ligands in binding sites of protein. J. Comput. Chem. 31, 2014-2022 (2010).
43. Ohto, U., Fukase, K., Miyake, K. & Satow, Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316, 1632-1634 (2007).
44. Pal, D. et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipidinduced insulin resistance. Nat. Med. 18, 1279-1285 (2012).
45. Anderson, S. G., Sanders, T. A. & Cruickshank, J. K. Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension 53, 839-845 (2009).
46. Winhofer, Y. et al. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects. Diabetes 61, 1210-1216 (2012).
47. Ebbesson, S. O. et al. Fatty acids linked to cardiovascular mortality are associated with risk factors. Int. J. Circumpolar. Health. 74, 20855 (2015).
48. da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S. & Ulevitch, R. J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276, 21129-21135 (2001).
49. Gioannini, T. L. et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl Acad. Sci. USA 101, 4186-4191 (2004).
50. Suganami, T., Nishida, J. & Ogawa, Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25, 2062-2068 (2005).
51. Lee, J. Y. et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278, 37041-37051 (2003).
52. Hwang, D. H., Kim, J. A. & Lee, J. Y. Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur. J. Pharmacol. 785, 24-35 (2016).
53. Pan, Y. et al. Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart. J. Nutr. Biochem. 24, 146-155 (2013).
54. Laugwitz, K. L. et al. Postnatal isl1 cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653 (2005).
55. Guo, D. et al. Loss of PI3Kgamma enhances cAMP-dependent MMP remodelling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress. Circ. Res. 107, 1275-1289 (2010).
56. Wang, Y. et al. MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis. Br. J. Pharmacol. 172, 4391-4405 (2015).
57. Triantafilou, M., Triantafilou, K. & Fernandez, N. Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influencedby endotoxin concentration. Eur. J. Biochem. 267, 2218-2226 (2000).
58. Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785-2791 (2009).
59. DeLano, W. L. The PyMOL Molecular Graphics System. http://www.pymol.org (2002).
60. Frisch, M. J. et al. Gaussian 09, Revision A.02 (Gaussian, Inc., Wallingford, CT, USA, 2009).
61. Wang, J., Wang, W., Kollman, P. A. & Case, D. A. Antechamber: an accessory software package for molecular mechanical calculations. J. Am. Chem. Soc. 222, U403 (2001).
62. Wickstrom, L., Okur, A. & Simmerling, C. Evaluating the performance of the ff99SB force field based on NMR scalar coupling data. Biophys. J. 97, 853-856 (2009).
63. Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157-1174 (2004).
64. Pearlman, D. A. et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput. Phys. Commun. 91, 1-41 (1995).
65. Salomon-Ferrer, R., Case, D. A. & Walker, R. C. An overview of the Amber biomolecular simulation package. Wiley Interdiscip. Rev. Comput. Mol. Sci. 3, 198-210 (2013).
66. Shirts, R. B., Burt, S. R. & Johnson, A. M. Periodic boundary condition induced breakdown of the equipartition principle and other kinetic effects of finite sample size in classical hard-sphere molecular dynamics simulation. J. Chem. Phys. 125, 164102 (2006).
67. Sagui, C. & Darden, T. A. Molecular dynamics simulations of biomolecules: long-range electrostatic effects. Annu. Rev. Biophys. Biomol. Struct. 28, 155-179 (1999).
68. Kräutler, V., Van Gunsteren, W. F. & Hu7die;nenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22, 501-508 (2001).